Taking all the above into consideration, it is vital to understand that SGLT-2 inhibitors should only be used under the guidance of a healthcare professional and should not be used by individuals with T1DM or those with severe kidney disease, as their mechanism of action relies on adequate kidney function. The gene discussed is SLC5A2; the disease is type 1 diabetes mellitus.